galactosamine has been researched along with carnitine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evengard, B; Kanakura, Y; Kawata, S; Kitani, T; Kuratsune, H; Långström, B; Lindh, G; Machii, T; Matsumura, K; Takahashi, M; Takaishi, J; Watanabe, Y; Yamaguti, K | 1 |
| Abdin, MZ; Ahad, A; Farooqi, H; Ganai, AA; Jahan, S | 1 |
| Farooqi, H; Ganai, AA; Ganaie, IA; Verma, N | 1 |
3 other study(ies) available for galactosamine and carnitine
| Article | Year |
|---|---|
Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases.
Topics: Acute Disease; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Fatigue Syndrome, Chronic; Female; Galactosamine; Hepatitis C, Chronic; Humans; Japan; Male; Mice; Mice, Inbred C3H; Neoplasms; Sweden | 1998 |
Glycine propionyl l-carnitine attenuates d-Galactosamine induced fulminant hepatic failure in wistar rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Ataxia Telangiectasia Mutated Proteins; Base Sequence; Carnitine; Comet Assay; DNA Primers; Galactosamine; Glutathione; Glycine; Lipid Peroxidation; Liver Failure, Acute; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2014 |
Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage.
Topics: Actins; Animals; Body Weight; Carnitine; Chronic Disease; Collagen Type I; Galactosamine; Gene Expression Regulation; Glycine; Hydroxyproline; In Situ Nick-End Labeling; Interleukin-6; Liver; Liver Cirrhosis; Male; Oxidative Stress; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine | 2016 |